Skip to main content Skip to search Skip to main navigation

Evaluation of the environmental risks of medicinal products (free guideline)

0 reviews

Average rating of 0 out of 5 stars

Leave a review!

Share your experiences with other customers.

Product information

Why Do You Need an Environmental Risk Assessment?

Nowadays, the application for placing a medicinal product for human use on the market requires an environmental risk assessment report. This report must be based on the instructions of the EMA's Guideline on the Environmental Risk Evaluation of Medicinal Products for Human Use (Doc. Ref. EMEA/CHMP/SWP/4447/00 corr. 2).

How to Obtain an Elemental Impurities Risk Assessment

The proven and successful collaboration between Azierta and GMP-Verlag Peither AG provides you with an economically priced alternative to conventional elemental impurities risk assessments. Following verification of the critical key data, we will be pleased to send you a binding, fixed price quote.

What You Get With Us

We provide comprehensive reports for the analysis and assessment of possible environmental risks of an API:

  • Evaluation procedures based on the current EU guideline: EMEA/CHMP/SWP/4447/00 corr 2.
  • Phase I: Estimation of exposure
  • Phase II: Environmental fate and effects analysis
  • Risk Assessment for each API using the latest version of the IQVIA database.
  • Specialised environmental toxicologists with extensive experience in new drug registrations.

Information Required for a Fixed Price Quote

To prepare a binding, fixed price quote, please provide the following information:

  • Company name and address
  • Name of the medicinal product
  • Country in which the product is to be sold
  • Maximum daily dose

Do You Have Questions?

Talk to our customer advisors

Do you have any questions about our products and services? We are here to help.

Customer Reviews

0 reviews

Average rating of 0 out of 5 stars

Leave a review!

Share your experiences with other customers.

Skip product gallery

y

PDE Report | Sample Document

PDE Report | Sample Document

Why do you need a PDE report? As of June 1st, 2016, health-based exposure limits must be determined for all APIs of human and veterinary medicinal products produced in multi-purpose facilities. >>> More information Our service includes Issuing of the PDE report According to EMA guideline in English Issued on your company name according to EMA guideline requirements Issued by European toxicological experts Brief explanation/training of the report 10–15 minutes in English Conducted by a toxicologist via Skype after delivery This is what we need from you to prepare a quote: Company name and address Name of the API Dosage form Route of application of the API or of the potential next product produced in the same facility (for cleaning validation)

Ready for dispatch, Delivery time appr. 2-5 workdays (2-3 weeks for christmas goodies)
€0.00 net excl. VAT
Elemental Impurities Risk Assessment | Sample Document

Elemental Impurities Risk Assessment | Sample Document

Why do you need an elemental impurities risk assessment? As of June 2016, all new medicinal products have to be evaluated based on the ICH guideline Q3D on elemental impurities. As of December 2017, this guideline came into effect for already authorised medicinal products as well. Therefore, every authorised medicinal product has to be evaluated. How to obtain an elemental impurities risk assessment? The proven and successful collaboration between Azierta and GMP-Verlag Peither AG provides you with an economically priced alternative to conventional elemental impurities risk assessments. Following verification of the critical key data, we will be pleased to send you a binding, fixed price quote. Our service includes Issuing of the elemental impurities risk assessment According to ICH Q3D guideline in English Issued for the specific medicinal product according to ICH Q3D guideline Issued by European toxicological experts This is what we need from you to prepare a binding, fixed price quote Company name and address Name of the medicinal product

Ready for dispatch, Delivery time appr. 2-5 workdays (2-3 weeks for christmas goodies)
€0.00 net excl. VAT
How to implement ICH Q3D of elemental impurities in 5 steps (free manual)

How to implement ICH Q3D of elemental impurities in 5 steps (free manual)

Why do you need an elemental impurities risk assessment?As of June 2016, all new medicinal products have to be evaluated based on the ICH guideline Q3D on elemental impurities. As of December 2017, this guideline came into effect for already authorised medicinal products as well. Therefore, every authorised medicinal product has to be evaluated.How to obtain an elemental impurities risk assessment? The proven and successful collaboration between Azierta and GMP-Verlag Peither AG provides you with an economically priced alternative to conventional elemental impurities risk assessments. Following verification of the critical key data, we will be pleased to send you a binding, fixed price quote. Our service includes: Issuing of the elemental impurities risk assessment according to ICH Q3D guideline in English issued for the specific medicinal product according to ICH Q3D guideline issued by European toxicological experts This is what we need from you to prepare a binding, fixed price quote Company name and address Name of the medicinal product Completed questionnaire

Ready for dispatch, Delivery time appr. 2-5 workdays (2-3 weeks for christmas goodies)
€0.00 net excl. VAT